$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
AHF's Gilead Shareholder Resolution Seeks Transparency on Patent Exclusivities
06:15pm, Monday, 27'th Apr 2026
LOS ANGELES--(BUSINESS WIRE)-- #AHFcares--AHF's Gilead Shareholder Resolution Seeks Transparency on Patent Exclusivities.
Brindle & Bay Financial Advisors LLC Purchases Shares of 6,042 Gilead Sciences, Inc. $GILD
04:39am, Sunday, 26'th Apr 2026
Brindle and Bay Financial Advisors LLC purchased a new stake in Gilead Sciences, Inc. (NASDAQ: GILD) during the fourth quarter, according to the company in its most recent disclosure with the Securiti
AEGON ASSET MANAGEMENT UK Plc Reduces Holdings in Gilead Sciences, Inc. $GILD
03:11am, Sunday, 26'th Apr 2026
AEGON ASSET MANAGEMENT UK Plc trimmed its stake in Gilead Sciences, Inc. (NASDAQ: GILD) by 8.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Comm
Calamos Advisors LLC Sells 9,121 Shares of Gilead Sciences, Inc. $GILD
03:58am, Saturday, 25'th Apr 2026
Calamos Advisors LLC lessened its stake in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 3.9% during the fourth quarter, according to the company in its most recent filing with the Securities and
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
06:51pm, Friday, 24'th Apr 2026
Gilead Sciences (GILD) reached $130.4 at the closing of the latest trading day, reflecting a -2.42% change compared to its last close.
Atwood & Palmer Inc. Has $42.94 Million Holdings in Gilead Sciences, Inc. $GILD
03:59am, Friday, 24'th Apr 2026
Atwood and Palmer Inc. lifted its position in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 1.7% in the undefined quarter, according to the company in its most recent Form 13F filing with the Secu
Breakfast News: IBM Hit by Inflation's Long Shadow
07:30am, Thursday, 23'rd Apr 2026
IBM warns of potential consumer slowdown, Microsoft targets AI push in Australia, and more
Gilead Sciences to Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
04:05pm, Wednesday, 22'nd Apr 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #Earnings--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2026 financial results and guidance will be released on Thursday, May 7, 2
Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now?
12:30pm, Tuesday, 21'st Apr 2026
BMY stands out vs GILD, supported by a cheaper valuation, strong growth portfolio, and improving earnings outlook despite generic headwinds.
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors
07:00pm, Monday, 20'th Apr 2026
In the closing of the recent trading day, Gilead Sciences (GILD) stood at $135.87, denoting a -1.29% move from the preceding trading day.
Gilead Sciences: Why I'm Tempted To Sell Ahead Of Q1 Earnings - But Won't
03:59pm, Monday, 20'th Apr 2026
Gilead Sciences: Why I'm Tempted To Sell Ahead Of Q1 Earnings - But Won't
Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term
10:42am, Monday, 20'th Apr 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Gilead Sciences (NASDAQ:GILD) Insider Sells $422,880.00 in Stock
04:36am, Sunday, 19'th Apr 2026
Gilead Sciences, Inc. (NASDAQ: GILD - Get Free Report) insider Johanna Mercier sold 3,000 shares of the stock in a transaction on Wednesday, April 15th. The shares were sold at an average price of $14
Gilead Sciences (NASDAQ:GILD) CFO Sells $422,880.00 in Stock
04:36am, Sunday, 19'th Apr 2026
Gilead Sciences, Inc. (NASDAQ: GILD - Get Free Report) CFO Andrew Dickinson sold 3,000 shares of the business's stock in a transaction dated Wednesday, April 15th. The shares were sold at an average p
Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer
08:30am, Friday, 17'th Apr 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that all required regulatory approvals have been obtained for its previously announced acquisition of Arcellx
Sign In
Buy GILD